Efficacy and Safety Profile of Fluticasone Furoate Administered Once Daily in the Morning or Evening: A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled Trial in Adult and Adolescent Patients With Persistent Bronchial Asthma

Efficacy and Safety of Tadalafil Once Daily in the Treatment of Men With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: Results of an International Randomized, Double-Blind, Placebo-Controlled Trial

European Urology ◽

10.1016/j.eururo.2011.08.005 ◽

2011 ◽

Vol 60 (5) ◽

pp. 1105-1113 ◽

Cited By ~ 119

Author(s):

Hartmut Porst ◽

Edward D. Kim ◽

Adolfo R. Casabé ◽

Vincenzo Mirone ◽

Roberta J. Secrest ◽

...

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Controlled Trial ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

Double Blind ◽

Once Daily ◽

Double Blind Placebo ◽

Urinary Tract Symptoms ◽

Re: Hartmut Porst, Edward D. Kim, Adolfo R. Casabé, et al., for the LVHJ study team. Efficacy and Safety of Tadalafil Once Daily in the Treatment of Men With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: Results of an International Randomized, Double-Blind, Placebo-Controlled Trial. Eur Urol 2011;60:1105–13

European Urology ◽

10.1016/j.eururo.2012.02.016 ◽

2012 ◽

Vol 61 (5) ◽

pp. e45-e46

Author(s):

Ege Can Serefoglu ◽

Gregory C. Mitchell ◽

Wayne J.G. Hellstrom

Keyword(s):

Lower Urinary Tract ◽

Controlled Trial ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

Double Blind ◽

Once Daily ◽

Team Efficacy ◽

Urinary Tract Symptoms ◽

Study Team ◽

Efficacy and Safety of Tadalafil Once Daily in the Treatment of Men With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: Results of an International Randomized, Double-Blind, Placebo-Controlled Trial

Yearbook of Urology ◽

10.1016/j.yuro.2011.11.006 ◽

2012 ◽

Vol 2012 ◽

pp. 178-180

Author(s):

A.W. Shindel

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Controlled Trial ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

Double Blind ◽

Once Daily ◽

Double Blind Placebo ◽

Urinary Tract Symptoms ◽

Efficacy and Safety of Once-Daily Dosing of Udenafil in the Treatment of Erectile Dysfunction: Results of a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Yearbook of Urology ◽

10.1016/j.yuro.2011.08.008 ◽

2012 ◽

Vol 2012 ◽

pp. 95-96

Author(s):

A.W. Shindel

Keyword(s):

Erectile Dysfunction ◽

Controlled Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Once Daily ◽

Efficacy and Safety of the Once-Daily GLP-1 Receptor Agonist Lixisenatide in Monotherapy: A randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes (GetGoal-Mono)

Diabetes Care ◽

10.2337/dc11-1935 ◽

2012 ◽

Vol 35 (6) ◽

pp. 1225-1231 ◽

Cited By ~ 154

Author(s):

V. A. Fonseca ◽

R. Alvarado-Ruiz ◽

D. Raccah ◽

G. Boka ◽

P. Miossec ◽

...

Keyword(s):

Type 2 Diabetes ◽

Receptor Agonist ◽

Controlled Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Once Daily ◽

Liquid Formulation of AbobotulinumtoxinA Exhibits a Favorable Efficacy and Safety Profile in Moderate to Severe Glabellar Lines: A Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Trial

Aesthetic Surgery Journal ◽

10.1093/asj/sjw272 ◽

2017 ◽

Vol 38 (2) ◽

pp. 183-191 ◽

Cited By ~ 7

Author(s):

Benjamin Ascher ◽

Philippe Kestemont ◽

Dominique Boineau ◽

Isaac Bodokh ◽

Annette Stein ◽

...

Keyword(s):

Safety Profile ◽

Controlled Trial ◽

Efficacy And Safety ◽

Liquid Formulation ◽

Double Blind ◽

Double Blind Placebo ◽

Active Comparator

Efficacy and safety of linagliptin 2.5 mg twice daily versus 5 mg once daily in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, placebo-controlled trial

Current Medical Research and Opinion ◽

10.1185/03007995.2012.714360 ◽

2012 ◽

Vol 28 (9) ◽

pp. 1465-1474 ◽

Cited By ~ 30

Author(s):

Stuart A. Ross ◽

Elizabeth Rafeiro ◽

Thomas Meinicke ◽

Robert Toorawa ◽

Sonja Weber-Born ◽

...

Keyword(s):

Type 2 Diabetes ◽

Controlled Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Once Daily ◽

Efficacy and Safety of Fluticasone Furoate Nasal Spray in Japanese Children with Perennial Allergic Rhinitis: A Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial

Allergology International ◽

10.2332/allergolint.14-oa-0688 ◽

2014 ◽

Vol 63 (4) ◽

pp. 543-551 ◽

Cited By ~ 3

Author(s):

Kimihiro Okubo ◽

Arisa Okamasa ◽

Gosuke Honma ◽

Masaki Komatsubara

Keyword(s):

Allergic Rhinitis ◽

Nasal Spray ◽

Controlled Trial ◽

Efficacy And Safety ◽

Perennial Allergic Rhinitis ◽

Fluticasone Furoate ◽

Japanese Children ◽

Double Blind ◽

Efficacy and safety of once-daily fluticasone furoate/vilanterol (FF/VI) versus twice-daily inhaled corticosteroids/long-acting β2-agonists (ICS/LABA) in patients with uncontrolled asthma: An open-label, randomized, controlled trial

Respiratory Medicine ◽

10.1016/j.rmed.2018.06.009 ◽

2018 ◽

Vol 141 ◽

pp. 111-120 ◽

Cited By ~ 3

Author(s):

Philippe Devillier ◽

Marc Humbert ◽

Alain Boye ◽

Wolfgang Zachgo ◽

Loretta Jacques ◽

...

Keyword(s):

Inhaled Corticosteroids ◽

Controlled Trial ◽

Efficacy And Safety ◽

Uncontrolled Asthma ◽

Fluticasone Furoate ◽

Open Label ◽

Once Daily ◽

Randomized Controlled ◽

Long Acting ◽

Β2 Agonists

Faculty Opinions recommendation of Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results of an international randomized, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13753956.15174056 ◽

2012 ◽

Author(s):

Viorel Bucuras ◽

Razvan Bardan

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Controlled Trial ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

Double Blind ◽

Once Daily ◽

Double Blind Placebo ◽

Urinary Tract Symptoms ◽